Bausch Health Companies Inc. (BHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1B 2B 3B Q3 '21: 2.1B Q4 '21: 2.2B Q1 '22: 1.9B Q2 '22: 2B Q3 '22: 2B Q4 '22: 2.2B Q1 '23: 1.9B Q2 '23: 2.2B Q3 '23: 2.2B Q4 '23: 2.4B Q1 '24: 2.2B Q2 '24: 2.4B Q3 '24: 2.5B Q4 '24: 2.6B Q1 '25: 2.3B Q2 '25: 2.5B Q3 '25: 2.7B Q4 '25: 2.8B Q1 '26: 2.5B Q2 '26: 2.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-1.1B -700M -350M 0 350M 700M 1.1B Q2 '21: -270M Q3 '21: 574M Q4 '21: 367M Q1 '22: 285M Q2 '22: 161M Q3 '22: 244M Q1 '23: 175M Q2 '23: 412M Q3 '23: 14M Q4 '23: 362M Q1 '24: 281M Q2 '24: 389M Q3 '24: 318M Q4 '24: 558M Q1 '25: 276M Q2 '25: 444M Q3 '25: 619M Q4 '25: 474M Q1 '26: -950M Q2 '26: 740M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '21: 188M Q4 '21: 69M Q1 '22: -69M Q2 '22: -145M Q3 '22: 399M Q4 '22: -410M Q1 '23: -201M Q2 '23: 26M Q3 '23: -378M Q4 '23: -39M Q1 '24: -64M Q2 '24: 10M Q3 '24: -85M Q4 '24: 93M Q1 '25: -58M Q2 '25: 148M Q3 '25: 179M Q4 '25: -112M Q1 '26: -1.4B Q2 '26: 258M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '21: 564M Q4 '21: 24M Q1 '22: -63M Q2 '22: 123M Q3 '22: -1.3B Q4 '22: 475M Q1 '23: 154M Q2 '23: 206M Q3 '23: 282M Q4 '23: 390M Q1 '24: 211M Q2 '24: 380M Q3 '24: 405M Q4 '24: 601M Q1 '25: 211M Q2 '25: 289M Q3 '25: 405M Q4 '25: 495M Q1 '26: 230M Q2 '26: 670M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '21: 501M Q4 '21: -54M Q1 '22: -109M Q2 '22: 71M Q3 '22: -1.3B Q4 '22: 409M Q1 '23: 107M Q2 '23: 178M Q3 '23: 240M Q4 '23: 292M Q1 '24: 129M Q2 '24: 302M Q3 '24: 334M Q4 '24: 495M Q1 '25: 96M Q2 '25: 190M Q3 '25: 314M Q4 '25: 403M Q1 '26: 121M Q2 '26: 593M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 353.4M Q2 '20: 355.3M Q3 '20: 357.8M Q1 '21: 356.8M Q2 '21: 359.1M Q3 '21: 364M Q1 '22: 360.8M Q2 '22: 362.2M Q3 '22: 363.4M Q1 '23: 363.3M Q2 '23: 367.1M Q3 '23: 365.4M Q1 '24: 366.8M Q2 '24: 370.2M Q3 '24: 368.4M Q1 '25: 369.6M Q2 '25: 373.1M Q3 '25: 375.5M Q1 '26: 372.8M Q2 '26: 378.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -3.28 Q4 '21: -2.64 Q1 '22: -1.12 Q2 '22: 0.14 Q3 '22: 0.72 Q4 '22: -0.62 Q1 '23: -0.98 Q2 '23: -0.51 Q3 '23: -2.64 Q4 '23: -1.61 Q1 '24: -1.23 Q2 '24: -1.27 Q3 '24: -0.47 Q4 '24: -0.13 Q1 '25: -0.12 Q2 '25: 0.25 Q3 '25: 0.96 Q4 '25: 0.42 Q1 '26: -3.24 Q2 '26: -2.96 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.